Literature DB >> 15857343

The European working time directive: implications for subspecialty acute care.

G O Hellawell1, L Kahn, F Mumtaz.   

Abstract

The requirements of the new deal for junior doctors' hours has meant that many smaller trusts are unable to provide adequate cover on-call for medical and surgical subspecialties. The care of the acute subspecialty patients has, therefore, shifted to general teams in many trusts. We assessed what impact this had upon the outcome of acute urological cases in our district general hospital by prospectively monitoring acute renal colic admissions over a 12-month period and surveyed the provision of services in other regional hospitals. The shift in care of the acute urological patient was associated with considerable morbidity for patients admitted in our hospital. The additional financial burden due to this morbidity was estimated to be 33000 pounds/annum. The implementation of the new deal must be achieved with every care to minimise the clinical and financial costs of withdrawing acute subspecialty services.

Entities:  

Mesh:

Year:  2005        PMID: 15857343     DOI: 10.1111/j.1368-5031.2005.00508.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  3 in total

1.  Training in the practical application of damage control and early total care operative philosophy--perceptions of UK orthopaedic specialist trainees.

Authors:  W G P Eardley; D M Taylor; P J Parker
Journal:  Ann R Coll Surg Engl       Date:  2009-12-07       Impact factor: 1.891

2.  A prospective audit of emergency urology activity in a university teaching hospital.

Authors:  E J Redmond; J C Forde; M A Abdelrahman; N P Kelly; C Akram; S K Giri; H D Flood
Journal:  Ir J Med Sci       Date:  2014-06-06       Impact factor: 1.568

3.  The value of the post-take ward round: are new working patterns compromising junior doctor education?

Authors:  M Chaponda; M Borra; N J Beeching; D S Almond; P S Williams; M A Hammond; V A Price; L Tarry; M Taegtmeyer
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.